Financial & Business News
LATEST INVESTING HEADLINES
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against ASML Holding NV ("ASML" or the "Company") (NASDAQ:ASML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Wolfspeed, Inc. ("Wolfspeed" or the "Company") (NYSE:WOLF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ:EVLV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Zeta Global Holdings Corp. ("Zeta" or the "Company") (NYSE:ZETA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. ("Kyverna" or the "Company") (NASDAQ:KYTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. ("PACS" or the "Company") (NYSE:PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=118031&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacs-group-inc-lawsuit-submission-form?prid=118033&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against TMC the metals company Inc. ("TMC" or the "Company") (NASDAQ:TMC) and certain officers. The class action, filed in the United States District Court for the Central District Of California, and docketed under 24-cv-09684 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired TMC securities between May 12, 2023 and March 25, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.